Haleos Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the audited financial results (Standalone ....
HALEOSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Haleos Labs Ltd (formerly SMS Lifesciences India Limited) has informed BSE and NSE about its 97th Board meeting scheduled for May 29, 2026. The meeting will consider and approve the audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2026. The Board will also discuss recommending a dividend for FY 2025-26. The trading window remains closed for designated persons until May 31, 2026. This is a routine regulatory intimation under SEBI LODR regulations and does not contain any financial details or material disclosures at this stage.
This is a standard meeting notice with no immediate shareholder impact. The actual financial results and dividend decision will be disclosed after the meeting. Investors should note the trading window closure period.